ArticleAmerican journal of preventive medicine2023
Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings.
Article in American journal of preventive medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed.
- Trial
- Racial disparities in time to treatment initiation and survival outcomes in patients with vulvar cancer: a national cancer database analysis.International journal of clinical oncology · 2026Observational
- Patient and System Factors Associated with Second-generation Antipsychotic Metabolic Lab Monitoring, a Retrospective Cohort Study.Community mental health journal · 2026Article
- Cervical Cancer Screening Preferences in Transgender, Nonbinary, and Gender-diverse Patients.O&G open · 2026Article
- Acceptability of HPV self-sampling in three urban academic emergency departments.BMC public health · 2026Article
- Racial Differences in Expected Versus Actual Costs of Cervical Cancer Screening among Low-Income, Underscreened Women in North Carolina.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Cervical Cancer Screening and Prevention among Latinas in the United States among a Network of Community Health Centers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Large Language Models for Breast and Cervical Cancers Communication: Mixed Methods Evaluation Study Assessing Linguistic Quality, Safety, and Accessibility.JMIR cancer · 2026Article
- "She's Always Made Sure That We Had Black Doctors, Particularly Women Doctors If We Could… and How It Can Sometimes Be the Difference Between Life and Death." Black College Women's Reflections On Medical Racism As a Social Determinant of Health.Journal of racial and ethnic health disparities · 2026Article
- Adherence to Obstetrician-/Gynecologist-Ordered Multi-target Stool DNA Test Screening and Follow-Up Colonoscopy: A National Multi-payer Study of US Women.Advances in therapy · 2026Article
- Relationships Between Vaccine Knowledge, Hesitancy, and Conspiracy Beliefs on COVID-19, Influenza, and HPV Vaccination.Journal of racial and ethnic health disparities · 2026Article
- Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years.JAMA network open · 2026Article
- Posttraumatic Stress Disorder Symptoms and Gynecological-Related Distress in Trauma-Exposed Women Veterans.Journal of women's health (2002) · 2026Article
- Kin KeeperJournal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
- Disparities in HPV/PAP Testing Among U.S. Women: A Cross-Sectional Analysis of Healthcare Access, Internet Use, and Sociodemographic Factors.Health science reports · 2026Article
- Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection.Journal of the American Board of Family Medicine : JABFM · 2026Article
- Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.JAMA network open · 2026Article
- Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.Analytical methods : advancing methods and applications · 2026Article
- Medicaid expansion and overall mortality among women with cervical cancer.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
- Health-related social media engagement and cervical cancer prevention: associations with HPV knowledge, vaccine awareness, and pap smear utilization among US women.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
introductionThis study sought to characterize racial and ethnic disparities in cervical cancer screening and follow-up of abnormal findings across 3 U.S. healthcare settings.
methodsData were from 2016 to 2019 and were analyzed in 2022, reflecting sites within the Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations Research Center, part of the Population-based Research to Optimize the Screening Process consortium, including a safety-net system in the southwestern U.S., a northwestern mixed-model system, and a northeastern integrated healthcare system. Screening uptake was evaluated among average-risk patients (i.e., no previous abnormalities) by race and ethnicity as captured in the electronic health record, using chi-square tests. Among patients with abnormal findings requiring follow-up, the proportion receiving colposcopy or biopsy within 6 months was reported. Multivariable regression was conducted to assess how clinical, socioeconomic, and structural characteristics mediate observed differences.
resultsAmong 188,415 eligible patients, 62.8% received cervical cancer screening during the 3-year study period. Screening use was lower among non-Hispanic Black patients (53.2%) and higher among Hispanic (65.4%,) and Asian/Pacific Islander (66.5%) than among non-Hispanic White patients (63.5%, all p<0.001). Most differences were explained by the distribution of patients across sites and differences in insurance. Hispanic patients remained more likely to screen after controlling for a variety of clinical and sociodemographic factors (risk ratio=1.14, CI=1.12, 1.16). Among those receiving any screening test, Black and Hispanic patients were more likely to receive Pap-only testing (versus receiving co-testing). Follow-up from abnormal results was low for all groups (72.5%) but highest among Hispanic participants (78.8%, p<0.001).
conclusionsIn a large cohort receiving care across 3 diverse healthcare settings, cervical cancer screening and follow-up were below 80% coverage targets. Lower screening for Black patients was attenuated by controlling for insurance and site of care, underscoring the role of systemic inequity. In addition, it is crucial to improve follow-up after abnormalities are identified, which was low for all populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.